Founded in 2006, Massachusetts-based biotechnology startup Gelesis has raised a total of $118.2 million for developing an oral smart pill. In 2016, the company initially filed an IPO offering of $60 million, but pulled out and instead focused on raising more funding. The technology is based on capsules filled with tiny hydrogel particles that expand between 50 to 100 times their weight in size after absorbing water from the stomach, which results in increased satiety to help obese diabetes patients lose weight and control their sugar metabolism. They are currently undergoing a phase 2 clinical trial on their Gelesis200 product for treating diabetes.
This seems hard to do, but really it’s not if you know one secret: Replace snacking with something far more satisfying — fat. That’s right, the government is wrong to recommend a low fat diet. Fat is what makes you feel full until your next meal. Take away the fat, take away the full. Don’t go to an extreme, but do lean strongly toward a high-fat low-carb diet.
In normal persons the hormone insulin, which is made by the beta cells of the pancreas, regulates how much glucose is in the blood. When there is excess glucose in the blood, insulin stimulates cells to absorb enough glucose from the blood for the energy that they need. Insulin also stimulates the liver to absorb and store any glucose that is excess in blood. Insulin release is triggered after a meal when there is rise in blood glucose. When blood glucose levels fall, during exercise for example, insulin levels fall too.
Dr. Richard A. Anderson, at the Human Nutrition Research Center (USDA), found that people who eat apple pie have a significantly lower probability of getting Type II diabetes. Upon further examination, he isolated cinnamon as the substance in the apple pies that was preventing diabetes. Within cinnamon, the key substance is a water soluble polyphenol type-A polymer as the effective ingredient. Here is a link to the article:
Vanadium is a compound found in tiny amounts in plants and animals. Early studies showed that vanadium normalized blood sugar levels in animals with type 1 and type 2 diabetes. When people with diabetes were given vanadium, they had a modest increase in insulin sensitivity and were able to lower their need for insulin. Researchers want to understand how vanadium works in the body, find potential side effects, and set safe dosages.
Since chronic pain has so many contributing causes — physical, mental, and emotional — there are many ways to break into the pain cycle, reduce pain levels, and gain comfort. There may not be a cure for chronic pain, but a person can gain some control over his pain. Feeling more in control, even a little bit, can help people relax, try new things, and gain even more control. In this way, even severe chronic pain can be managed, and the person with pain can gain better health in the process.
According to Christine Sullivan, founder of Real Help for Chronic Pain, an online pain management program, “Chronic pain is almost never merely a physical thing. We can see from brain mapping that chronic pain uses very different nerve paths from acute pain. In fact, the brain maps of chronic pain look just like the brain maps of intense emotions like anger, or sadness, or fear.”
Scientists are trying to figure out how to transplant islet cells and then protect them from the patient’s immune system so that long-term immunosuppressive medications aren’t required. Micro encapsulation is an approach scientists are testing to find out if a special coating to the transplanted islets can help the patient avoid rejection of those islets. These coatings let in nutrients to nourish the cells but prevent your body’s immune system from attacking them.
A 2017 article in the journal Diabetes Care explains that the goals for dietary change should be “healthful eating patterns emphasizing a variety of nutrient-dense foods in appropriate portion sizes.” Additional goals include achieving a healthy weight; attaining healthy blood sugar, blood pressure, and lipid levels; and reducing complications. The authors emphasize developing an individualized plan based on “personal and cultural preferences, health literacy and numeracy, access to healthful foods, willingness and ability to make behavioral changes, and barriers to change.”
Diarrhea and constipation may also stem from diabetes-related gut movement issues. And the conditions may be related. “Diarrhea doesn’t mean fast motion; constipation doesn’t mean slow movement,” says Mashimo, happy to clear up a common misconception. “They can be two sides of the same coin.” Constipation, he says, is caused by slow movement of the bowels, which can cause a buildup of harmful bacteria in the colon that, in turn, triggers diarrhea.
Big pharma are in the early stages of developing their own cell therapy approaches for diabetes. Novo Nordisk, one of the largest providers of diabetes treatments, is bidding for stem cells and an encapsulation device, stating that the first clinical trial could take place in the “next few years.” Sanofi, also a big name in diabetes, is working with the German Evotec in a beta cell replacement therapy for diabetics.
Travis and Ardell found a kindred spirit in Bill Hettler, a staff physician at the University of Wisconsin-Stevens Point. Influenced by their work, Hettler founded the annual National Wellness Conference at Stevens Point, now in its 35th year. The conference lent valuable academic prestige to the wellness movement. It also caught the attention of Tom Dickey, who was working with the New York publisher Rodney Friedman in the early 1980s to set up a monthly newsletter on health, based at the University of California, Berkeley. Friedman wanted the publication to compete with the Harvard Medical School Health Letter, and Dickey suggested using wellness in the title as a contrast. In 1984, the Berkeley Wellness Letter was born.
In patients with type 2 diabetes, stress, infection, and medications (such as corticosteroids) can also lead to severely elevated blood sugar levels. Accompanied by dehydration, severe blood sugar elevation in patients with type 2 diabetes can lead to an increase in blood osmolality (hyperosmolar state). This condition can worsen and lead to coma (hyperosmolar coma). A hyperosmolar coma usually occurs in elderly patients with type 2 diabetes. Like diabetic ketoacidosis, a hyperosmolar coma is a medical emergency. Immediate treatment with intravenous fluid and insulin is important in reversing the hyperosmolar state. Unlike patients with type 1 diabetes, patients with type 2 diabetes do not generally develop ketoacidosis solely on the basis of their diabetes. Since in general, type 2 diabetes occurs in an older population, concomitant medical conditions are more likely to be present, and these patients may actually be sicker overall. The complication and death rates from hyperosmolar coma is thus higher than in diabetic ketoacidosis.
The first step to treating diabetes is testing to determine if a person has the condition in the first place. Routine screening of type 2 diabetes is recommended after the age of 45 by the American Diabetes Association, especially for overweight individuals. Those who are living a sedentary lifestyle or have complicating risks for cardiovascular disease or other metabolic diseases are more likely to be screened earlier. After determining if a patient has diabetes, a physician will usually recommend they undergo a lifestyle change towards healthy diet and exercise, but most people also require the help of diabetes medications and insulin therapy.
By the late 2000s the concept had become widely used in employee assistance programs in workplaces, and funding for development of such programs in small business was included in the Affordable Care Act. The use of corporate wellness programs has been criticised as being discriminatory to people with disabilities. At the same time, while there were magazines devoted to wellness, it was noted that mainstream news sources had begun to devote more page space to "health and wellness themes".